共 8 条
[1]
[2]
[3]
[4]
Increased production of circulating soluble co-stimulatory molecules CTLA-4; CD28 and CD80 in patients with rheumatoid arthritis[J] Ju Cao;Lin Zou;Peixin luo;Pu Chen;Liping Zhang International Immunopharmacology 2012,
[5]
Circulating Soluble CTLA4 (sCTLA4) Is Elevated in Patients With Breast Cancer[J] Erfani;Razmkhah;Ghaderi Cancer Investigation 2010,
[6]
Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population[J] Priya Sakthivel;Fredrik Wermeling;Anders Elmgren;Johannes Hulthe;Maria Kakoulidou;Ann Kari Lefvert;Lars Lind Scandinavian Journal of Clinical & Laboratory Inv 2010,
[7]
Association of Cytotoxic T Lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer[J] Ruiping Hou;Bangwei Cao;Zhongdong Chen;Yong Li;Tao Ning;Chunhui Li;Changqing Xu;Ziping Chen Molecular Biology Reports 2010,
[8]
A soluble form of CTLA-4ispresent in paediatric patients with acute lymphoblastic leukaemiaand correlates with CD1d+expression Simone R;Tenca C;Fais F;et al; PLoS One 2012,

